iShares Biotechnology ETF
IBB NASDAQ
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 6.99B as of Feb 2020
- Expense ratio
- 0.47% per year
- Dividend yield
- 0.17% Quarterly
- Volatility · 1Y
- 22.2% Above Average
- Beta
- 0.77 vs the market
- 52-week range
- 150.64216.95
How IBB has paid off
Price return over every period, and total return with dividends reinvested, set against its benchmark.
Return by period
Price · to Oct 12Total return vs benchmark
Total Market US Cap Weighted 1200 IndexOver 1 year, IBB returned +35.8% with dividends reinvested — −17.9 pts behind its benchmark.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±22% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −9.6% on Mar 27, 2026 — 64 days after the previous high
More than 5% below a high 18% of the time.
Risk vs reward
1YOver 1 year, IBB delivered less return with more risk than its benchmark.
Market sensitivity
BetaA beta of 0.77 means IBB has moved less than the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average205.53 −0.6%
- 26-day average205.92 −0.8%
- 50-day average203.26 +0.5%
- 200-day average183.73 +11.2%
The price is above 2 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
NeutralRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
by Sector · Health Care — tracking the ICE Biotechnology Index (TR).
- Assets under management6.99BUSD
- Expense ratio0.47%per year
- Holdings219
- Risk score4.8Medium
Launched February 2001. Listed options available. Fund data as of Feb 28, 2020.
What it pays you
Cash distributions over the last twelve months, and how they have grown.
About 2 USD a year for every 1,000 USD invested at today's price.
- Per share
- 0.34
- Frequency
- Quarterly
- Last paid
- Sep 15, 2026
Last 12 months
0.34 USD / shareWhere IBB shows up
Curated themes and indices that hold IBB. Open one to see it in context, or test the whole theme in a portfolio.
About iShares Biotechnology ETF
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
- Featured in 1 curated theme
- 219 holdings
- Ticker
- IBB
- Exchange
- NASDAQ
- ISIN
- US4642875565
- CUSIP
- 464287556
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- by Sector
- Industry
- Health Care
- Benchmark
- Total Market US Cap Weighted 1200 Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 28, 2020
Put IBB to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.